Intrapleural fibrinolytic treatment of traumatic clotted hemothorax

dc.contributor.authorInci, I
dc.contributor.authorÖzçelik, C
dc.contributor.authorÜlkü, R
dc.contributor.authorTuna, A
dc.contributor.authorEren, N
dc.date.accessioned2024-04-24T17:15:22Z
dc.date.available2024-04-24T17:15:22Z
dc.date.issued1998
dc.departmentDicle Üniversitesien_US
dc.description.abstractStudy objective: To evaluate the role of intrapleural fibrinolytic treatment (IPFT) in traumatic clotted hemothorax. Design and patients: Between August 1995 and February 1997, 24 patients with traumatic clotted hemothorax were included. Streptokinase (SK), 250,000 IU, or urokinase (UK), 100,000 IU, diluted in 100 mt of saline solution was givers daily. We administered 5.0+/-1.8 (range, 2 to 9) doses of SK or 6.25+/-5,97 (range, 2 to 15) doses of UK, Setting: Dicle University School of Medicine, Thoracic and Cardiovascular Surgery Department. Results: Complete response, which was defined as resolution of symptoms with complete drainage of fluid and no residual space radiographically, occurred in 15 (62.5%) patients, Partial response, which was defined as resolution of symptoms with a small pleural cavity, occurred in severs (29.2%) patients, Two patients (8.3%) required decortication; they were defined as nonresponders, The mean period of time between the diagnosis and fibrinolytic treatment (FT) was 11.65+/-6.38 (range, 4 to 25) days, There were no complications related to IPFT, There was no mortality during the course of IPFT. Conclusion: The use of intrapleural fibrinolytic agents has resulted in resolution of clotted hemothorax with an overall success rate of 91.7%. We recommend that IPFT should be added to the algorithm for management of clotted hemothorax before proceeding with minithoracotomy or pleural decortication.en_US
dc.identifier.doi10.1378/chest.114.1.160
dc.identifier.endpage165en_US
dc.identifier.issn0012-3692
dc.identifier.issue1en_US
dc.identifier.pmid9674464
dc.identifier.scopus2-s2.0-0031844110
dc.identifier.scopusqualityQ1
dc.identifier.startpage160en_US
dc.identifier.urihttps://doi.org/10.1378/chest.114.1.160
dc.identifier.urihttps://hdl.handle.net/11468/18432
dc.identifier.volume114en_US
dc.identifier.wosWOS:000074837100030
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherAmer Coll Chest Physiciansen_US
dc.relation.ispartofChest
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectClotted Hemothoraxen_US
dc.subjectIntrapleural Fibrinolysisen_US
dc.subjectStreptokinaseen_US
dc.subjectTraumaen_US
dc.subjectUrokinaseen_US
dc.titleIntrapleural fibrinolytic treatment of traumatic clotted hemothoraxen_US
dc.titleIntrapleural fibrinolytic treatment of traumatic clotted hemothorax
dc.typeArticleen_US

Dosyalar